/ Glenmark Receives Tentative ANDA Approval For Solifenacin Succinate Tablets ~ Ways2Capital|Stock Tips|Stock Market Tips|Intraday Stock Tips|Stock Trading Tips|NSE BSE Tips

Thursday, 22 June 2017

Glenmark (USA) granted a tentative approval by the USFDA (United States Food & Drug Administration) for Solifenacin Succinate Tablets, 5 mg and 10 mg, the Generic version of Vesicare Tablets, 5mg and 10 mg of the Astellas Pharma US Inc.

The company was trading higher by 1% at around Rs 635/share and BSE Healthcare Index trading higher by 0.53% on 14,140 levels. Sequence is the top gainer in the index trading higher of Rs 125.7 or 4.6a % / share and other pharma stocks like Fortis, Alembic pharma, Jubilant and Oil Chemical and pharma are also trading in the positive territory.

On Thursday morning the Nifty and Sensex was trading higher by more than a quarter percent, Nifty is trading 33 points higher and Sensex is trading by 128 points higher.

or Quick Trial – 8962000225 ✔ 
or mail us here: info@ways2capital.com
or visit http://www.ways2capital.com
✆ - 0731-6626222 | Toll Free - 1800-3010-2007 ✔ 
Give a Missed Call for Free Trial - 09699997717 ✔